Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics
Sponsor: Jeffrey
Summary
Children are commonly hospitalized because of community-acquired pneumonia. Despite the fact that many of these children have viral disease, a majority is treated with antibiotics. These antibiotics will not accelerate recovery in those with viral pneumonia and can cause harm. We are interested in exploring whether the MeMed BV - a composite biomarker assay - could be used to improve antibiotic prescribing in these children by identifying those who likely have viral disease. This proposal describes a feasibility randomized trial of this diagnostic intervention.
Official title: Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: a Feasibility Randomized Controlled Trial of a Diagnostic Intervention
Key Details
Gender
All
Age Range
6 Months - 18 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2024-04-17
Completion Date
2026-01-01
Last Updated
2024-12-10
Healthy Volunteers
No
Conditions
Interventions
MeMed BV + Usual Care
We will aim to have blood drawn for MeMed BV testing within 24 hours of the first dose of IV antibiotics. We will then aim to have test results back within 24 hours of sampling.
Usual Care Alone
Usual care can involve oxygenation support, ventilatory support, intravenous fluids, and antibiotics, or any combination of these.
Locations (1)
McMaster Children's Hospital
Hamilton, Ontario, Canada